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Abstract

Author Manuscript

WAP-8294A is a family of at least 20 cyclic lipodepsipeptides exhibiting potent anti-MRSA
activity. These compounds differ mainly in the hydroxylated fatty acyl chain; WAP-8294A2, the
most potent member of the family that reached clinical trials, is based on (R)-3-hydroxy-7methyloctanoic acid. It is unclear how the acyl group is incorporated because no acyl-CoA ligase
(ACL) gene is present in the WAP-8294A gene cluster in Lysobacter enzymogenes OH11. Here,
we identified seven putative ACL genes in the OH11 genome and showed that the yield of
WAP-8294A2 was impacted by multiple ACL genes with the ACL6 gene having the most
significant effect. We then investigated several (R)-3-hydroxy fatty acids and their acyl SNAC (Nacetylcysteamine) thioesters as substrates for the ACLs. Feeding (R)-3-hydroxy-7methyloctanoate-SNAC to the ACL6 gene deletion mutant restored the production of
WAP-8294A2. Finally, we heterologously expressed the seven ACL genes in E. coli and purified
six of the proteins. While these enzymes exhibit a varied level of activity in vitro, ACL6 showed
the highest catalytic efficiency in converting (R)-3-hydroxy-7-methyloctanoic acid to its CoA
thioester when incubated with coenzyme A and ATP. These results provided both in vivo and in
vitro evidence to support the fact that ACL6 is the main player for fatty acyl activation and
incorporation in WAP-8294A2 biosynthesis. The results also suggest that the molecular basis for
the acyl chain diversity in the WAP-8294A family is the presence of functionally overlapping
ACLs.

Introduction

Author Manuscript

The discovery of new anti-infective drugs is a pressing and continual need for human health
due to the constant emergence of drug resistant pathogens.1,2 Nosocomial infections caused
by methicillin-resistant Staphylococcus aureus (MRSA) have become an especially serious
clinical problem. It is imperative to discover and develop new antibiotics. Natural products
(NPs) are the most significant source of anti-infectives3 and we have been using Lysobacter
species as a new source for bioactive NP discovery.4–10 WAP-8294A (Fig. 1), a family of
compounds displaying anti-MRSA activity, are cyclic lipodepsipeptides originally isolated
*
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from Lysobacter staphylocidin.11–13 Cyclic depsipeptides belong to a large and diverse
family of nonribosomally synthesized peptides that have a wide variety of important
biological activities.14–16 WAP-8294A2 (lotilibicin), the most potent antibacterial of the
family, exhibit 14-fold greater anti-MRSA activity compared with vancomycin; an IV
formulation was in phase-I clinical studies in 2010.12,17,18

Author Manuscript

Although WAP-8294A compounds were first isolated nearly two decades ago, the study of
their biosynthetic mechanism was reported only in 2011.11,12 Improved understanding of the
molecular mechanism of biosynthesis could open rational approaches to generate new
analogs with improved clinical properties. We have identified the WAP biosynthetic gene
cluster from L. enzymogenes OH11, which includes two large nonribosomal peptide
synthetase (NRPS) genes. The NRPSs comprise a total of 12 modules that make 45
functional domains, which are responsible for the assembly of the 12-amino acid core
structure of WAP-8294A compounds.11

Author Manuscript

The WAP-8294A family all contains a 3-acyloxy amide linkage derived from a (R)-3hydroxy fatty acyl chain; individual family members differ in the length of the chain and the
presence or absence of a branching methyl group (Fig. 1). The fatty acids must be activated
before incorporation into the peptide. The mechanism is likely to involve activation of fatty
acids to their corresponding acyl coenzyme A (CoA) thioesters by a family of acyl CoA
ligases (ACL). This catalytic process occurs in two steps and involves requisite formation of
an acyladenylate (acyl-AMP) intermediate.19 Acyl CoA ligases are usually located within
the biosynthetic cluster associated with formation of the remainder of the natural product.
For example, the gene clusters for amphi-enterobactin,20 daptomycin16 and calciumdependent antibiotic (CDA)21 all host a dedicated ACL and an ACP (acyl carrier protein) for
the activation and incorporation of the fatty acyl chain. It is therefore interesting that there is
no ACL gene present in or near the WAP gene cluster,11 a phenomenon previously observed
with the gene cluster for surfactin.22 In addition, no dedicated ACP is present within the
WAP cluster. These features suggest that the WAP-8492A biosynthetic pathway likely
recruits an ACL in trans and that the fatty acids are directly activated as acyl-S-CoA
thioesters, instead of acyl-S-ACP, for the incorporation into the peptide core.

Author Manuscript

The aim of this work is to determine the molecular basis for activation and incorporation of
fatty acyl chains in the biosynthesis of members of the WAP-8294A family, particularly for
the most eminent member WAP-8294A2. Here we describe both the in vivo and in vitro
results obtained from the study of seven putative ACLs found in the genome of L.
enzymogenes OH11. Our study shows that multiple ACLs contribute to WAP-8294A
biosynthesis and that ACL6 is the most important enzyme in the activation of (R)-3hydroxy-7-methyloctanoic acid and incorporation into WAP-8294A2.

Results and discussion
Multiple acyl-CoA ligases contribute to WAP-8294A biosynthesis
We identified seven putative ACL genes in the genome of L. enzymogenes OH11 that are
associated with secondary metabolism (Fig. S1A). The ACL genes are either associated with
NRPS-PKS gene clusters, or adjacent to genes related to biosynthesis and regulation of
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natural products, such as genes encoding lantibiotic-modifying enzyme, enoyl-CoA
hydratase, or two-component regulatory system. To test if any of the ACLs is involved in
WAP-8294A biosynthesis, we disrupted each of the 7 ACL genes (Fig. S2 and S3). The
HPLC and MS analysis showed that the disruption of ACL1, ACL5, and ACL7 had little
impact on the yield of WAP-8294A2, whereas the disruption of ACL2, ACL3, ACL4, and
ACL6 significantly reduced the yield (Fig. 2). In particular, the ACL6 mutant produced a
barely detectable amount of WAP-8294A2. Thus we mainly focused on ACL6 in subsequent
experiments. The results suggest that multiple ACLs contribute to the fatty acyl chain
activation and incorporation in WAP-8294A2 biosynthesis, and the ACLs are functionally
redundant.
Feeding fatty acyl precursor restored WAP-8294A2 production in ACL6 in-frame deletion
mutants

Author Manuscript

To eliminate potential polar effects caused by insertion of the conjugal vector in the gene
disruption mutants, we also generated in-frame deletion mutants for ACL6 gene (Fig. S3).
WAP-8294A2 production in this mutant strain was monitored by HPLC and MS (Fig. 3).
Similar to that in the ACL6 disruption mutant, WAP-8294A2 production in the in-frame
deletion mutant was nearly completely eliminated. We chemically synthesized the N-acetyl
cysteamine thioester (SNAC) of (R)-3-hydroxy-7-methyloctanoic acid (Fig. 4); details are
provided in Supplementary Information. This compound was used as the acyl-CoA
surrogate to be fed to the ACL6 deletion mutant. HPLC analysis clearly showed that
WAP-8294A2 production was restored in the ACL6 mutant (Fig. 3). This result
demonstrated that ACL6 is the predominant enzyme responsible for fatty acyl incorporation
into WAP-8294A2.

Author Manuscript

Heterologous expression of ACL genes and in vitro assay of the enzyme activity
We cloned the seven putative ACL genes in pET28A and heterologously expressed the
genes in E. coli. The expressed proteins were purified, except ACL2 which was produced
mostly as an insoluble protein (Fig. S4). As judged by SDS-PAGE, the observed molecular
masses of ACL1 through ACL7, including the His6 tag, were consistent with the predicted
masses (58.7, 58.8, 60.4, 59.8, 61.0, 47.2, 58.6 kDa) calculated from the amino acid
sequences (Fig. S4).

Author Manuscript

The enzyme activity of ACLs 1–7 was measured by incubating the enzymes with (R)-3hydroxy-7-methyloctanoic acid, ATP, and CoA. A distinct peak in HPLC was detected
around 9.2 min in the reaction containing ACL6. This peak was collected and analyzed by
MS, which gave a [M+H]+ of m/z 924.93, consistent with the mass of 3-hydroxy-7methyloctanoyl-CoA (calculated mass 923.23) (Fig. 5 and S5). Tandem mass spectrometry
was used to fragment the analytes into product ions. Both the fatty acyl-CoA precursor ion
(m/z 924.30) and its product ions (m/z 428.10, 417.20) were detected, while the control
reaction (w/o enzyme) only gave the product ions of CoA (m/z 480.10 and m/z 261.20). The
results support the hypothesis that ACL6 catalyzes acyl-CoA formation from the fatty acid
and CoA. Other ACL also showed some activity, but the product was formed in such minute
amounts that the peak could only be detected by MS. In addition, we tested (R)-3hydroxyoctanoic acid, which corresponds to the fatty acyl portion of WAP-8294A1 (Fig. 1).
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HPLC and MS data showed a peak around 9 min that gave a [M+H]+ of m/z 911.00 when
ACL5 was incubated with (R)-3-hydroxyoctanoic acid, CoA and ATP (data not shown). The
result indicates that ACL5 is able to catalyze the acyl-CoA formation from (R)-3hydroxyoctanoic acid and CoA.
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To further confirm the specificity of the enzymes, we performed kinetic analysis, using
EnzChek Pyrophosphate Assay Kit. The inorganic pyrophosphatase in this kit catalyzes
conversion of PPi into two equivalents of Pi. The Pi is then consumed by the 2-amino-6mercapto-7-methyl-purine ribonucleoside (MESG) by purine ribonucleoside phosphorylase
(PNP) and the product, 2-amino-6-mercapto-7-methyl purine, is detected by an increase in
absorbance at 360 nm. The EnzChek Pyrophosphate Assay Kit had been used for the
quantitation of PPi in solution or for the continuous determination of PPi released in
enzymatic reactions.23–25 To measure the activity, ACL was incubated with free fatty acid,
ATP, CoA and the coupled reaction system provided by the kit as described above. The
kinetic parameters were determined by initial velocity experiments using the coupled assay
(Table S2A and S2B). These data were globally fitted to Michaelis-Menten Equation,
yielding Km values for (R)-3-hydroxy-7-methyloctanoic acid and (R)-3-hydroxyoctanoic
acid. The data confirmed that ACL6 favored (R)-3-hydroxy-7-methyloctanoic acid as
substrate, while ACL5 had a faster rate when (R)-3-hydroxyoctanoic was the substrate. The
relatively slow reaction rates might explain the very low yield of WAP-8294A in L.
enzymogenes.11 No steady signal was detected in the enzyme-free or ATP-free control
reactions, showing that the detected signals resulted from the enzymatic activity of ACLs.

Conclusions
Author Manuscript

Cyclic lipopeptides are an important group of bioactive natural products; this is exemplified
by the new antibiotic daptomycin (Cubicin). Although many of the peptides exhibit activity,
WAP-8294A2 is exceptionally potent against MRSA (ED50 14-fold lower than
vancomycin). WAP-8294A2 reached the Phase-I clinical studies, but appears to have been
discontinued from the clinical development.18 The reason for discontinuation has not been
published, but could indicate undesirable pharmaco-properties. The understanding of
WAP-8294A biosynthetic mechanism is an essential step toward rational engineering the
biosynthetic machinery to produce new analogs with improved properties. In WAP-8294A
biosynthesis, the mechanism by which the 3-hydroxy fatty acyl chain is incorporated into
the peptide is the least understood step.

Author Manuscript

To get more insights into the molecular basis for the fatty acyl incorporation and
WAP-8294A structural diversity, we searched the genome of L. enzymogenes OH11 and
identified seven putative ACL genes. We disrupted each of the seven ACL genes and found
that none of the mutants completely lost WAP production. The result supports the notion
that multiple ACL genes are involved in the acyl incorporation, and the function of the
ACLs is likely redundant. Among the seven mutants, ACL6 appeared to have the highest
impact on the yield of WAP-8294A2. To prove this, we generated in-frame deletion mutant
of ACL6 to eliminate potential polar effects caused by gene disruption. We then chemically
synthesized the acyl-CoA surrogate, (R)-3-hydroxy-7-methyloctanoyl SNAC. WAP-8294A2
production in the ACL6 deletion mutant was restored upon feeding the synthetic acyl-CoA
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surrogate. The result confirms ACL6’s role in WAP-8294A2 biosynthesis; it also suggests
that ACL6 is required for substrate activation, but not NRPS priming. The results support
that the WAP-8492A biosynthetic pathway recruits ACL in trans and that the first
condensation domain in the WAP-8492A NRPS can accept acylS-CoA for the incorporation
of the fatty acyl chain into the peptide core. Interestingly, a phylogenetic analysis of the
condensation domains of a group of selected NRPS showed that the first C domain of
WAP-8492A NRPS (WAP_WAPS1_C1) falls into the same subgroup that includes the first
C domain of Calcium-Dependent Antibiotics (CDA) and Daptomycin, whose biosynthesis
uses acyl-ACP as substrate (Fig. S1B).

Author Manuscript

In the in vitro studies, we were able to express six of the seven putative ACL genes in E. coli
and to purify the proteins for enzyme activity assay and kinetic studies. The enzyme activity
was demonstrated by the conversion of the chemically synthesized (R)-3-hydroxy fatty acids
to the corresponding CoA thioesters, when the purified ACLs were incubated with the
substrate, CoA and ATP. The kinetic data revealed that (R)-3-hydroxy-7-methyloctanoic
acid is the preferred substrate for ACL6. These observations are consistent with the results
obtained from ACL mutants and in vivo feeding experiment. Together, the results support
that ACL6 is the most important enzyme for fatty acyl incorporation into WAP-8294A2, and
ACL5 may be an important contributor for the fatty acyl incorporation into WAP-8294A1.
Based on the results presented in this study, we propose a mechanism for the initiation of the
biosynthesis of WAPs, as shown in Fig. 6.

Experimental procedures
Chemicals, bacterial strains, plasmids, and general procedures for DNA manipulation

Author Manuscript

Chemicals used in this study were purchased from Fisher Scientific, Sigma, and Acros.
Oligonucleotide primers for PCR were synthesized by Eurofins MWG Operon. Plasmid
preparation and DNA extraction were carried out with Qiagen kits (Valencia, CA), and all
other DNA manipulations were carried out according to standard methods. Ni-NTA agarose
was purchased from Qiagen (Valencia, CA). Escherichia coli strain XL Blue was used as
the host for general plasmid DNA propagation, and the cloning vector was pANT841.
Vector pET28a was used for protein expression in E. coli BL21 (DE3). E. coli S17-1 was
used as the conjugal strain to transfer DNA into Lysobacter. L. enzymogenes and other
bacterial strains were grown in Luria-Bertani (LB) broth medium, 1/10-strength tryptic soy
broth (1/10 TSB, Sigma) or NYGB/A medium. EnzChek Pyrophosphate Assay Kit was
purchased from Sigma.
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Generation of gene disruption mutants
To construct plasmids for gene disruption, an internal fragment was amplified from each of
the open reading frames (ORFs) using the primer pairs described in Supporting Information
(Table S1). Genomic DNA from the wild type L. enzymogenes OH11 served as the PCR
template. The homologous regions of these ACLs were amplified by PCR and introduced
into the conjugation vector pJQ200SK to produce pJQ200SK-ACLs. Each of the pJQ200SK
constructs was transformed into E. coli S17-1, which was mated with L. enzymogenes OH11
for conjugal transfer of the vectors. The positive colonies grown on LB plates containing
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gentamicin (20 μg/mL) were picked up and inoculated into liquid cultures containing
gentamicin. Genomic DNA was prepared from each of the cultures, and diagnostic PCR was
performed to identify mutants that resulted from a homologous recombination. To screen the
ACL gene disruption mutants, PCR was performed using the diagnostic primers listed in
Table S1, which would amplify correct fragments when mutants resulted from a
homologous recombination, but not from the wild type or mutants resulted from a random
insertion of the construct (Fig. S2 and S3).
Production and analysis of metabolites in mutant strains

Author Manuscript

L. enzymogenes OH11 and its mutants were grown in 1/10 TSB for 1 day, and an aliquot of
200 l was spread on a solid NYGA plate (bacteriological peptone, 5 g/L; yeast extract, 3
g/L; glycerol, 20 g/L, and agar 15 g/L). The plates were incubated at 28 °C for 2 days. To
extract the metabolites, the solid media were collected and extracted with methanol. The
methanol extract was dried with a rotavapor (Buchi, Rotavapor R-200) to afford the crude
extract, which was dissolved in 2 mL methanol containing 0.05% TFA. A 20 μl aliquot of
each of the extracts was analyzed by HPLC (1220 Infinity LC, Agilent Technologies) using
a reversed-phase column (Cosmosil 5C18-AR-II, 4.6 ID × 250 mm). Water/0.01 M TFA
(solvent A) and acetonitrile/methanol = 1:1 (solvent B) were used as the mobile phases with
a flow rate of 1.0 mL/min. The HPLC program was as follows: 57% B in A in the first 5
min, 57–100% B in 5–32 min, 100% B in 32–40 min, back to 57% B at 41 min, and
maintained to 48 min. The metabolites were detected at 280 nm on a UV detector. LCQ-MS
was used to verify the mass of the peak of WAP-8294A2 and analogs.
Generation of gene deletion mutants

Author Manuscript
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To construct the ACL6 in-frame deletion vector, primer extension PCR reactions were
performed to generate a 705-bp fragment from both the upstream and downstream regions of
ACL6 gene. Homologous recombination at both regions would delete the entire ACL6 gene
without interference with other genes. The primers used for these experiments are listed in
the Table S1. The PCR amplified fragment was then cloned into the conjugal vector
pJQ200SK as an XhoI/BamHI fragment to produce pJQ200SK-ACL-6. To conjugally
transfer pJQ200SK-ACL-6 into L. enzymogenes OH11, the procedure was identical to the
previously described.11 The correct single crossover mutant was selected by diagnostic PCR
(Fig. S3). Individual colonies of confirmed single crossover mutants were subjected to liquid
cultures containing 5% (W/V) sucrose to select for the loss of the vector through a second
homologous recombination. The single crossover mutants were grown in 1/10 TSB medium
for 14 hours. Then the individual cultures were re-inoculated into 1/10 TSB (with 1:100
ratio) containing 5% sucrose and 25 μg/mL kanamycin medium. Aliquots (50 μl) were
removed every 3 hours from this liquid culture and spread onto 1/10 TSA plates (5%
sucrose, 25 μg/mL kanamycin). Single colonies were picked up from the plates and allowed
to grow in 1/10 TSB (5% sucrose, 25 μg/mL kanamycin) liquid medium for another 2–5
days. To confirm the double crossover mutant, another diagnostic PCR was performed using
genomic DNA extracted from the single colonies as template (Fig. S3).
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To generate the initial carbon backbone, we generated the dianion of methyl acetoacetate
with LDA then subsequent alkylation with an appropriate bromoalkane to create the target
carbon skeleton in roughly 20c50% yields (1a–b) (Fig. 4).26 A subsequent asymmetric
reduction of the β-keto ester with borane dimethyl sulfide complex in the presence of a
commercial oxazaborolidine catalyst provides the beta hydroxy esters 2a–b in 20–40% yield
with a 90–92% enantiomeric excess of the R isomer.27 Hydrolysis of the methyl esters to the
carboxylic acids can be accomplished in almost quantitative yield (3a–b) in the presence of
LiOH. Selective formation of thioesters 4a–b in the presence of the free alcohol is
accomplished in 70–80% yield through carbodiimide-mediated coupling with SNAC in the
presence of stoichometric DCC and catalytic DMAP (see Supporting Information for
details).
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Feeding of ACL6 deletion mutant with 3-hydroxy-7-methyloctanoyl SNAC
ACL6 in-frame deletion mutant was grown in 1/10 TSB for 1 day, and an aliquot of 1 mL
was inoculated into two 1 liter NYGB liquid cultures. The culture was fed with the fatty
acyl-SNAC dissolved in DMSO under pulse feeding on 2 following days (0.12 mmol/L and
0.06 mmol/L) following a reported procedure.28 Metabolites were extracted from the
supernatant with ethyl acetate: methanol: acetic acid = 80: 15: 5. The organic phase was
dried under reduced pressure (rotary evaporator) to afford the crude extract. The extract was
dissolved in 2 mL methanol containing 0.05% TFA. A 20 μl aliquot of each of the extracts
was analyzed by HPLC as described above.
Expression of seven ACL genes and purification of the enzymes

Author Manuscript
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To construct expression vectors, the coding region of each of the seven ACL genes was
amplified by PCR using genomic DNA of L. enzymogenes OH11 as template. The primers
are listed in Table S1. Each of the PCR fragments was digested and cloned into pANT841.
The cloned gene in each of the constructs was sequenced, and the result showed that all the
ACL sequences were correct. The ACL genes were released from pANT841 and cloned into
the expression vector pET28a. The pET28a constructs were introduced into E. coli
BL21(DE3). Individual colonies were inoculated in 3 mL of liquid LB medium containing
kanamycin (50 μg/mL) and incubated in a shaker (250 rpm) at 37 °C overnight. The culture
was then added to 50 mL fresh LB medium and incubated in a shaker (250 rpm) at 37 °C
until the cell density (OD600) reached 0.6. To induce the expression of the ACL genes, IPTG
(0.1 mM) was added to the cultures, and the cells were allowed to grow at the same
conditions for another 3 h. To extract proteins, the cells were harvested and resuspended in 2
mL of Tris-HCl buffer (250 mM NaCl, 100 mM LiCl, 50 mM Tris, pH 7.8). The cell
suspension was treated with lysozyme (1 mg/mL) and sonicated five times (3-second
sonication with 2-second pause) on ice. The soluble fraction of protein extracts was loaded
onto a Ni-NTA column, which was previously calibrated with Tris buffer containing 10 mM
imidazole. The column was washed three times with Tris buffer containing 20 mM
imidazole, and the His6-tagged protein was eluted twice with 200 μl of Tris buffer
containing 250 mM imidazole. The eluted proteins were checked by SDS-PAGE (Fig. S4).
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The fractions containing pure ACLs were collected and dialyzed against Tris buffer
containing 15 % glycerol.
In vitro assay of acyl-CoA ligase activity
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Enzymatic reactions to generate fatty acyl-CoA were set up using the following conditions:
10 μM ACL, 0.2 mM CoA, 10 mM ATP, 20 μM fatty acid in DMSO, 5 mM MgCl2, 0.2%
(w/v) Triton, 200 μM DTT, and 100 mM Tris-HCl pH 7.8. All reactions were incubated at
30 °C overnight. Samples were analyzed by HPLC (1220 Infinity LC, Agilent Technologies)
using a reversed-phase column (Phenomenex, 4.6 ID × 150 mm). Water containing 25 mM
ammonium acetate and 0.5% acetic acid (solvent A) and acetonitrile containing 0.5% acetic
acid (solvent B) were used as the mobile phases with a flow rate of 1.0 mL/min. The HPLC
program was as follows: 10% B in A in the first 3 min, 10–90% B in 3–15 min, 90% B in
15–25 min, back to 10% B at 26 min, and maintained to 30 min.29 The metabolites were
detected at 260 nm on a UV detector. MS (Finnigan mat, LCQ) was used to verify the mass
of the reaction products. LC-MS/MS was used to further confirm the product. An Agilent
LC-1200 (Santa Clara, CA) was connected to a 2.1 × 100 mm Symmetry ODS column from
Waters (Milford, MA) and a Triple Quadrupole Mass Spectrometer model 4000 QTrap from
ABSciex (Framingham, MA) operating in either single quadrupole (Q1), enhanced mass
spectrum (EMS), MS/MS or multiple reaction monitoring (MRM) modes. The samples were
injected onto the column and eluted with 98% mobile phase A (0.1% formic acid in water,
J.T. Baker) to 60% B (0.1% formic acid in acetonitrile, Acros Organics) over 15 minutes,
followed by 5 minutes of 98% B and 5 min of 98 % A, all at a flow rate of 0.25 mL/min.
Kinetic analysis of acyl-CoA ligase activity
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The EnzChek Pyrophosphate Assay Kit (Molecular Probes™) was used to measure the
activities of ACLs. A standard curve (y = 0.0156x + 0.0004, R2 = 0.99603) for the
pyrophosphate assay was generated using pyrophosphate standard as a source of PPi. To
measure the activity of ACLs, the following reagents were combined in 0.1 mL reaction
volumes: 0.4 mM ATP, 0.4 mM CoA, 0.4 mM free fatty acids in DMSO, 0.2 mM 2amino-6-mercapto-7-methyl-purine ribonucleoside (MESG), 1 U purine nucleoside
phosphorylase (PNP), 0.01 U pyrophosphatase, and various ACLs with final concentration
of 15 μM. After incubating at 22 °C for 30 minutes, the absorbance at 360 nm was measured
and corrected for background absorbance. The substrates tested were chemically synthesized
(R)-3-hydroxy-7-methyloctanoic acid (corresponding to the fatty acyl chain in WAP 8294A2) and (R)-3-hydroxyloctanoic acid (corresponding to the fatty acyl chain in WAP 8294A1). The kinetic parameters of ACLs were determined by initial velocity experiments using
the coupled assay. These data were globally fitted to Michaelis-Menten Equation, yielding
Km values for the substrates.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1.

Structure of the two main members of the WAP-8294A family.
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Fig. 2.
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HPLC analysis of metabolites from various strains of Lysobacter enzymogenes OH11. A:
OH11 wild type; B-H: disruption mutants of ACL1 through ACL7, respectively; I:
WAP-8294A2 standard. The detection wavelength was 280 nm.
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Fig. 3.

Author Manuscript

HPLC analysis of metabolites in strains of Lysobacter enzymogenes OH11. A: ACL6 inframe deletion mutant; B: The ACL6 mutant supplemented with (R)-3-hydroxy-7methyloctanoic acyl-SNAC; C: WAP-8294A2 standard.
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Fig. 4.

Chemical synthesis of (R)-3-hydroxy fatty acids and 3-hydroxy fatty acyl-SNAC (acyl
thioester of N-acetyl cysteamine).
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Fig. 5.
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HPLC and MS analysis of in vitro reaction products of ACL6 incubated with 3-hydroxy-7methyloctanoic acid, ATP, and CoA. The ESI-MS signals were measured in positive single
ion mode. A: HPLC of control reaction (without enzyme); B: HPLC of ACL6 reaction; C:
ESI-MS analysis of the ACL6 reaction product, the distinct peak in HPLC as indicated by a
star. The calculated mass of 3-hydroxy-7-methyloctanoyl-CoA is 923.23 (see Fig. S5).
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Fig. 6.
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Proposed mechanism for fatty acid incorporation in WAP-8294A2 biosynthesis. The fatty
acid, (R)-3-hydroxy-7-methyloctanoic acid, is activated by ACL6, and the resultant acylCoA is then recognized by the condensation (C) domain of the NRPS, which catalyzes the
amide bond formation between the PCP-bound L-serine and the fatty acyl-CoA.
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